Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, AMENDED Notice of Meetings, 71082-71083 [2019-27711]

Download as PDF 71082 Federal Register / Vol. 84, No. 247 / Thursday, December 26, 2019 / Notices The following paragraph applies to all the collections of information covered by this notice: An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless the collection of information displays a valid OMB control number. Books or records relating to a collection of information must be retained if their contents may become material in the administration of any internal revenue law. Generally, tax returns and tax return information are confidential, as required by 26 U.S.C. 6103. Desired Focus of Comments: The Internal Revenue Service (IRS) is particularly interested in comments that: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including using appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., by permitting electronic submissions of responses. Comments submitted in response to this notice will be summarized and/or included in the ICR for OMB approval of the extension of the information collection; they will also become a matter of public record. Approved: December 10, 2019. R. Joseph Durbala, IRS Tax Analyst. [FR Doc. 2019–27751 Filed 12–23–19; 8:45 am] DEPARTMENT OF VETERANS AFFAIRS Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board, AMENDED Notice of Meetings The Department of Veterans Affairs (VA) gives notice under Federal Advisory Committee Act that the subcommittees of the Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board (JBL/CS SMRB) will be held on the dates below from 8:00 a.m. to 5:00 p.m. (unless otherwise listed) at the 20 F Conference Center, 20 F Street NW, Washington, DC 20001, the Phoenix Park Hotel, 520 North Capital Street NW, Washington, DC 20001, and at the Office of Research and Development, 1100 First Street NE, Washington, DC 20002: BILLING CODE 4830–01–P Meeting Date(s) khammond on DSKJM1Z7X2PROD with NOTICES BL/CS R&D Surgery Subcommittee ........................................................................................................................................ BL/CS R&D Pulmonary Medicine Subcommittee .................................................................................................................... BL/CS R&D Infectious Diseases-B Subcommittee ................................................................................................................. BL/CS R&D Oncology-A/D Subcommittee .............................................................................................................................. BL/CS R&D Hematology Subcommittee ................................................................................................................................. BL/CS R&D Oncology-C Subcommittee ................................................................................................................................. BL/CS R&D Cellular & Molecular Medicine Subcommittee .................................................................................................... BL/CS R&D Oncology-B/E Subcommittee .............................................................................................................................. BL/CS R&D Mental Health & Behavioral Sciences-P ............................................................................................................. BL/CS R&D Immunology & Dermatology-A Subcommittee .................................................................................................... BL/CS R&D Mental Health & Behavioral Sciences-C Subcommittee ..................................................................................... BL/CS R&D Cardiovascular Studies-A Subcommittee ............................................................................................................ BL/CS R&D Endocrinology-A Subcommittee .......................................................................................................................... BL/CS R&D Neurobiology-C Subcommittee ........................................................................................................................... BL/CS R&D Neurobiology-E Subcommittee ............................................................................................................................ BL/CS R&D Endocrinology-B Subcommittee .......................................................................................................................... BL/CS R&D Mental Health & Behavioral Sciences-A Subcommittee ..................................................................................... BL/CS R&D Nephrology Subcommittee .................................................................................................................................. BL/CS R&D Neurobiology-B Subcommittee ............................................................................................................................ BL/CS R&D Infectious Diseases-A Subcommittee ................................................................................................................. BL/CS R&D Neurobiology-F Subcommittee ............................................................................................................................ BL/CS R&D Cardiovascular Studies-B Subcommittee ............................................................................................................ BL/CS R&D Gastroenterology Subcommittee ......................................................................................................................... BL/CS R&D Neurobiology-P Subcommittee ............................................................................................................................ BL/CS R&D Neurobiology-R Subcommittee ........................................................................................................................... BL/CS R&D Neurobiology-A Subcommittee ............................................................................................................................ BL/CS R&D Neurobiology-D Subcommittee ........................................................................................................................... BL/CS R&D Gulf War Research Subcommittee ..................................................................................................................... BL/CS R&D VA Psychiatrist Development Award Subcommittee .......................................................................................... Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board. BL/CS R&D Eligibility Subcommittee ...................................................................................................................................... The purpose of the subcommittees is to provide advice on the scientific quality, budget, safety and mission relevance of investigator-initiated research proposals submitted for VA merit review evaluation. Proposals VerDate Sep<11>2014 16:53 Dec 23, 2019 Jkt 250001 submitted for review include various medical specialties within the general areas of biomedical, behavioral and clinical science research. The subcommittee meetings will be closed to the public for the review, PO 00000 Frm 00155 Fmt 4703 Sfmt 4703 November 12, 2019. November 13, 2019. November 14, 2019. November 14, 2019. November 15, 2019. November 15, 2019. November 18, 2019. November 18, 2019. November 19, 2019. November 20, 2019. November 20, 2019. November 21, 2019. November 21, 2019. November 21, 2019. November 22, 2019. November 25, 2019. December 3, 2019. December 3, 2019. December 3, 2019. December 4, 2019. December 4, 2019. December 5, 2019. December 5, 2019. December 5, 2019. December 5, 2019. December 6, 2019. December 6, 2019. December 6, 2019. January 8, 2019. January 8, 2019. January 17, 2020. discussion, and evaluation of initial and renewal research proposals. However, the JBL/CS SMRB teleconference meeting will be open to the public. Members of the public who wish to attend the open JBL/CS SMRB E:\FR\FM\26DEN1.SGM 26DEN1 Federal Register / Vol. 84, No. 247 / Thursday, December 26, 2019 / Notices khammond on DSKJM1Z7X2PROD with NOTICES teleconference may dial 1–800–767– 1750, participant code 50064#. Members of the public who wish to make a statement at the JBL/CS SMRB meeting must notify Dr. Holly Krull via email at holly.krull@va.gov by January 6, 2019. These subcommittee meetings will be closed to the public for the review, discussion, and evaluation of initial and renewal research proposals, which involve reference to staff and consultant critiques of research proposals. Discussions will deal with scientific merit of each proposal and qualifications of personnel conducting VerDate Sep<11>2014 16:53 Dec 23, 2019 Jkt 250001 the studies, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Additionally, premature disclosure of research information could significantly obstruct implementation of proposed agency action regarding the research proposals. As provided by subsection 10(d) of Public Law 92–463, as amended by Public Law 94–409, closing the subcommittee meetings is in accordance with Title 5 U.S.C. 552b(c)(6) and (9)(B). Those who would like to obtain a copy of the minutes from the closed subcommittee meetings and rosters of PO 00000 Frm 00156 Fmt 4703 Sfmt 9990 71083 the subcommittee members should contact Holly Krull, Ph.D., Manager, Merit Review Program (10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC 20420, at (202) 632–8522 or email at holly.krull@va.gov. Dated: December 18, 2019. LaTonya L. Small, Federal Advisory Committee Management Officer. [FR Doc. 2019–27711 Filed 12–23–19; 8:45 am] BILLING CODE 8320–01–P E:\FR\FM\26DEN1.SGM 26DEN1

Agencies

[Federal Register Volume 84, Number 247 (Thursday, December 26, 2019)]
[Notices]
[Pages 71082-71083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27711]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Joint Biomedical Laboratory Research and Development and Clinical 
Science Research and Development Services Scientific Merit Review 
Board, AMENDED Notice of Meetings

    The Department of Veterans Affairs (VA) gives notice under Federal 
Advisory Committee Act that the subcommittees of the Joint Biomedical 
Laboratory Research and Development and Clinical Science Research and 
Development Services Scientific Merit Review Board (JBL/CS SMRB) will 
be held on the dates below from 8:00 a.m. to 5:00 p.m. (unless 
otherwise listed) at the 20 F Conference Center, 20 F Street NW, 
Washington, DC 20001, the Phoenix Park Hotel, 520 North Capital Street 
NW, Washington, DC 20001, and at the Office of Research and 
Development, 1100 First Street NE, Washington, DC 20002:

------------------------------------------------------------------------
                  Meeting                              Date(s)
------------------------------------------------------------------------
BL/CS R&D Surgery Subcommittee............  November 12, 2019.
BL/CS R&D Pulmonary Medicine Subcommittee.  November 13, 2019.
BL/CS R&D Infectious Diseases-B             November 14, 2019.
 Subcommittee.
BL/CS R&D Oncology-A/D Subcommittee.......  November 14, 2019.
BL/CS R&D Hematology Subcommittee.........  November 15, 2019.
BL/CS R&D Oncology-C Subcommittee.........  November 15, 2019.
BL/CS R&D Cellular & Molecular Medicine     November 18, 2019.
 Subcommittee.
BL/CS R&D Oncology-B/E Subcommittee.......  November 18, 2019.
BL/CS R&D Mental Health & Behavioral        November 19, 2019.
 Sciences-P.
BL/CS R&D Immunology & Dermatology-A        November 20, 2019.
 Subcommittee.
BL/CS R&D Mental Health & Behavioral        November 20, 2019.
 Sciences-C Subcommittee.
BL/CS R&D Cardiovascular Studies-A          November 21, 2019.
 Subcommittee.
BL/CS R&D Endocrinology-A Subcommittee....  November 21, 2019.
BL/CS R&D Neurobiology-C Subcommittee.....  November 21, 2019.
BL/CS R&D Neurobiology-E Subcommittee.....  November 22, 2019.
BL/CS R&D Endocrinology-B Subcommittee....  November 25, 2019.
BL/CS R&D Mental Health & Behavioral        December 3, 2019.
 Sciences-A Subcommittee.
BL/CS R&D Nephrology Subcommittee.........  December 3, 2019.
BL/CS R&D Neurobiology-B Subcommittee.....  December 3, 2019.
BL/CS R&D Infectious Diseases-A             December 4, 2019.
 Subcommittee.
BL/CS R&D Neurobiology-F Subcommittee.....  December 4, 2019.
BL/CS R&D Cardiovascular Studies-B          December 5, 2019.
 Subcommittee.
BL/CS R&D Gastroenterology Subcommittee...  December 5, 2019.
BL/CS R&D Neurobiology-P Subcommittee.....  December 5, 2019.
BL/CS R&D Neurobiology-R Subcommittee.....  December 5, 2019.
BL/CS R&D Neurobiology-A Subcommittee.....  December 6, 2019.
BL/CS R&D Neurobiology-D Subcommittee.....  December 6, 2019.
BL/CS R&D Gulf War Research Subcommittee..  December 6, 2019.
BL/CS R&D VA Psychiatrist Development       January 8, 2019.
 Award Subcommittee.
Joint Biomedical Laboratory Research and    January 8, 2019.
 Development and Clinical Science Research
 and Development Services Scientific Merit
 Review Board.
BL/CS R&D Eligibility Subcommittee........  January 17, 2020.
------------------------------------------------------------------------

    The purpose of the subcommittees is to provide advice on the 
scientific quality, budget, safety and mission relevance of 
investigator-initiated research proposals submitted for VA merit review 
evaluation. Proposals submitted for review include various medical 
specialties within the general areas of biomedical, behavioral and 
clinical science research.
    The subcommittee meetings will be closed to the public for the 
review, discussion, and evaluation of initial and renewal research 
proposals. However, the JBL/CS SMRB teleconference meeting will be open 
to the public. Members of the public who wish to attend the open JBL/CS 
SMRB

[[Page 71083]]

teleconference may dial 1-800-767-1750, participant code 50064#. 
Members of the public who wish to make a statement at the JBL/CS SMRB 
meeting must notify Dr. Holly Krull via email at [email protected] by 
January 6, 2019.
    These subcommittee meetings will be closed to the public for the 
review, discussion, and evaluation of initial and renewal research 
proposals, which involve reference to staff and consultant critiques of 
research proposals. Discussions will deal with scientific merit of each 
proposal and qualifications of personnel conducting the studies, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy. Additionally, premature disclosure of research 
information could significantly obstruct implementation of proposed 
agency action regarding the research proposals. As provided by 
subsection 10(d) of Public Law 92-463, as amended by Public Law 94-409, 
closing the subcommittee meetings is in accordance with Title 5 U.S.C. 
552b(c)(6) and (9)(B).
    Those who would like to obtain a copy of the minutes from the 
closed subcommittee meetings and rosters of the subcommittee members 
should contact Holly Krull, Ph.D., Manager, Merit Review Program 
(10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW, 
Washington, DC 20420, at (202) 632-8522 or email at [email protected].

    Dated: December 18, 2019.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-27711 Filed 12-23-19; 8:45 am]
 BILLING CODE 8320-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.